Video

Jennifer Klemp Asks Unanswered Questions in Breast Cancer Survivorship

Author(s):

Jennifer Klemp, Ph.D., M.P.H.

Jennifer Klemp, Ph.D., M.P.H., asks the questions that remain unanswered in breast cancer survivorship.

Jennifer Klemp, Ph.D., M.P.H., asks the questions that remain unanswered in breast cancer survivorship.

First, she asks if every patient should get a survivorship plan. Klemp says they should, especially as there are now women with metastatic disease who are living for many years.

Next, she notes that survivorship education and symptom mitigation should be moved up to the time of diagnosis, not after treatment.

Finally, Klemp asks a pressing question on the minds of many patients and providers: how are we going to pay for all of this?

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of man.
Image of kelly.
Robotic and minimally invasive kidney cancer surgery may reduce pain, shorten recovery time and preserve kidney function, according to Dr. Armine Smith.
Image of Doctor.
Building long-term trust with providers can help patients with MPNs feel supported, encourage them to speak up and navigate care with confidence.
The field of radiation oncology has advanced in brain cancer treatment with precise therapeutic approaches including proton and carbon therapy.
Image of Dr. Doug
Image of doctor.
Image of Dr. Kelly
Image of Dr. Boffa.
Related Content
Image of two woman with pink ribbon.
May 16th 2025

Samuraciclib Therapy Combo Shows Responses in HR+ Advanced Breast Cancer

Ryan Scott
Recent phase 2 data support combination treatment with samuraciclib for those with HR+ advanced breast cancer following prior CDK4/6 inhibitor therapy.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
A Perjeta combo led to a significant overall survival benefit in HER2+ early-stage breast cancer: © stock.adobe.com.
May 13th 2025

Perjeta Regimen Improves Survival in HER2+ Early-Stage Breast Cancer

Spencer Feldman
Treatment with Perjeta, Herceptin and chemotherapy post-surgery led to a significant overall survival benefit in HER2-positive early-stage breast cancer.
Cancer Horizons podcast logo
December 12th 2023

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
Image of woman holding her chest.
May 10th 2025

Personalized Breast Cancer Care for Older Adults Goes Beyond Age

Ryan Scott
Dr. Hyman B. Muss discusses the unique facets of care that should inform personalized treatment decision-making for older patients with breast cancer.
Patti McGee is an author, a massage therapist and breast cancer survivor of 20 years. Catch up on all of Patti's blogs here!
May 8th 2025

Celebrating Nurses Week: The Heart and Soul of Our Cancer Community

Patti McGee
I’m 22 years out from breast cancer and forever grateful for the nurses who gave me not just treatment but friendship, laughter and a community of hope.